Ákos Schulcz

In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice

G. Mező, J. Tóvári, M. Manea, 2012, Anti-cancer drugs.

Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.

G. Mező, A. Marquardt, Ulrike Leurs, 2011, Bioconjugate chemistry.

Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice

G. Mező, Rózsa Hegedüs, J. Tóvári, 2016, Investigational New Drugs.

A mixture of amino acids and other small molecules present in the serum suppresses the growth of murine and human tumors in vivo

G. Kulcsár, Ákos Schulcz, T. Czömpöly, 2012, International journal of cancer.